Q&A – Impacts of COVID-19 on FAOD’s

Join MitoAction and Dr. Jerry Vockley from UPMC Children’s Hospital of Pittsburgh for a Q & A to discuss your questions and concerns about the impact of COVID-19 for Fatty Acid Oxidation Disorders.

If you have any additional questions that were not answered here, you can submit them to the “Ask the Expert” section on the INFORM website!

About the Speaker:

Dr. Vockley received his undergraduate degree at Carnegie-Mellon University in Pittsburgh, Pennsylvania, and received his degree in Medicine and Genetics from the University of Pennsylvania School of Medicine in Philadelphia. He is internationally recognized as a leader in the field of inborn errors of metabolism and fatty acid oxidation disorders research. Dr. Vockley’s current research focuses on the molecular architecture of mitochondrial energy metabolism, in which he is breaking new ground in describing the role of dysfunction of mitochondrial energy metabolism in such common conditions as diabetes, obesity, and Alzheimer disease. Dr. Vockley teaches at the University of Pittsburgh in both the Medical School and Graduate School of Public Health.

Date: 04/07/2020
Speaker: Dr. Jerry Vockley
Listen Now: Click Here

Related Articles

A LC-FAOD Treatment from Ultragenyx and Available Resources – for US members only
Date: 08/25/2021
Speaker: Bridget Reineking & Sylvia Mills
Ultragenyx Q&A – A Conversation with Ultragenyx’s CMO and Global Metabolic Dietitian
Date: 07/25/2020
Speaker: Camille Bedrosian & Bridget Reineking